Combination chemotherapy with adriamycin and cyclophosphamide
Fifty-five consecutive women with advanced breast cancer were treated with a combination of adriamycin (40 mg/m2 administered intravenously on day 1 ).
Combination chemotherapy for advanced breast cancer utilizing
is achieved with adriamycin and cyclophosphamide alone. Cancer 43:66-71 1979. OMBINAHON CHEMOTHERAPY IS AN effec-. C tive treatment of metastatic breast
BCCA Protocol Summary for Palliative Therapy for Metastatic Breast
01.02.2014 ... for Metastatic Breast. Cancer using DOXOrubicin and Cyclophosphamide ... Palliative treatment for patients with advanced breast cancer.
BRAVAC Protocol
Adriamycin combinations in advanced breast cancer: A
01.03.1982 regimen for treatment of advanced breast cancer. Adriamycin cyclophosphamide
Gene expression profiling of breast cancer patients treated with
chemotherapy with docetaxel (T) adriamycin (A) and cyclophosphamide (C) resulted in a rate of pCR of 17.9% in stage II–IV breast cancer disease.1 To.
Rody TheBreast
Chemotherapy in Advanced Breast Carcinoma Comparison
with metastatic breast cancer related to the re- sponse to chemotherapy
Adriamycin versus methotrexate in fiveâ•'drug combination
CMFVP consisted of cyclophosphamide (C) methotrexate (M)
BC Cancer Protocol Summary for Treatment of Locally Advanced
Breast Cancer using Doxorubicin and Cyclophosphamide followed by locally advanced and inflammatory breast cancer in patients less than or equal to 60.
BRLAACD Protocol
Phase II study of doxorubicin plus ifosfamide/mesna in patients with
01.06.1990 There were 31 women with poor prognosis advanced breast cancer in the study. ... Unlike cyclophosphamide ifosfamide is metabolized by.
Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally
Phase II Trial of Doxorubicin/Docetaxel/. Cyclophosphamide for Locally Advanced and. Metastatic Breast Cancer: Results from. NSABP Trial BP-58.
pdf?md = b b b fc aacd be dbe a e&pid= s . S main